Citadel Advisors’s BrightSpring Health Services BTSG Stock Holding History

Citadel Advisors’s Portfolio BTSG Stock Details BTSG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.1M	Sell	517,146 -2,570,778	-83%	-$143M	﹤0.01%	1892
2026 Q1	$132M	Buy	3,087,924 +2,940,026	+1,988%	+$118M	0.02%	644
2025 Q4	$5.54M	Sell	147,898 -106,049	-42%	-$3.56M	﹤0.01%	4135
2025 Q3	$7.51M	Sell	253,947 -2,225,191	-90%	-$51.7M	﹤0.01%	3674
2025 Q2	$58.5M	Buy	2,479,138 +2,166,932	+694%	+$45.2M	0.01%	1123
2025 Q1	$5.65M	Sell	312,206 -109,046	-26%	-$2.14M	﹤0.01%	3687
2024 Q4	$7.17M	Buy	421,252 +100,018	+31%	+$1.73M	﹤0.01%	3407
2024 Q3	$4.72M	Sell	321,234 -894,173	-74%	-$11.2M	﹤0.01%	4030
2024 Q2	$13.8M	Sell	1,215,407 -1,777,547	-59%	-$19.4M	﹤0.01%	2403
2024 Q1	$32.5M	Buy	+2,992,954	New	+$29.9M	0.01%	1580

Other funds holding BTSG

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's BTSG Position: Q2 2026 in Review

Citadel Advisors reduced its BrightSpring Health Services (BTSG) stake by 83% in Q2 2026, selling an estimated $143M and leaving 517,146 shares worth $36.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

Citadel Advisors first reported a position in BTSG in Q1 2024 and has held it in 10 quarters since. The position peaked at $132M in Q1 2026. 422 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

Citadel Advisors held 517,146 shares of BrightSpring Health Services worth $36.1M as of Q2 2026.
Citadel Advisors sold 2,570,778 BrightSpring Health Services shares in Q2 2026, an estimated $143M.
BrightSpring Health Services made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #1892 holding.
Citadel Advisors first reported a position in BrightSpring Health Services in Q1 2024 and has held it in 10 quarters since.
Citadel Advisors's BrightSpring Health Services position peaked at $132M in Q1 2026.
422 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.